Revolutionizing Life Sciences Tech: The Need for New Commercial Operating Models

"In an ever-evolving world, life sciences technology needs to adapt and revolutionize to meet patient needs and business demands better."

Transitioning to Value-Based Models

Pharmaceutical companies are searching for new and unique ways to reach customers that exceed their expectations. They now utilize advanced technology platforms that provide more than just prescriptions and basic instructions. These strategies effectively manage chronic and complicated illnesses like diabetes and multiple myeloma. Companies are reevaluating their commercial operating models to serve patients better and stay competitive.

Even though the restructuring process had already started before the pandemic, the COVID-19 crisis has emphasized the need for rapid and substantial changes in marketing strategies.

Digital Solutions: Empowering Patients and Enabling Clinicians

The life sciences industry, including biopharmaceutical manufacturers and medical device producers, is driven to create digital solutions that empower patients, enable clinicians, and integrate with a distributed care environment. These digital-first solutions facilitate patient engagement, compliance, and adherence as they accommodate the shift in care access points from traditional clinical settings to more convenient, home-based ones.

Emerging Marketing Trends in the Pharma Industry

The aftermath of the COVID-19 pandemic has compelled pharmacology experts to expand their marketing activities. The pandemic has accelerated research, and discoveries have opened new revenue streams for health drug and medical device manufacturers. Synthetic biology, for instance, is attracting venture funding and is seen as a promising industry that can provide essential medicines, green chemicals, and alternative foods.

Expanding Impact with Revolutionary Technology Platforms

Revolutionary technology platforms are helping science organizations extend their impact beyond just prescribing medications. Biopharmaceutical companies are now expected to design, deploy, and maintain digital solutions that are intuitive, interoperable, integrated, and intelligent to meet clinical and financial metrics tied with outcomes-based reimbursement models.

Biopharma manufacturers are developing digital solutions that deliver personalized therapies and provide clinicians with new insights, such as patient longitudinal or cohort data. However, this digital focus does not imply self-marketing or direct-to-consumer strategies. Instead, it reflects a change in the biopharma's perspective on patients, who are now seen as individual actors with technology preferences and an ability to participate in the design and delivery of their care.

The Challenge of Achieving Manufacturing Lifecycle Visibility

One critical aspect of remodeling pharmaceutical technology is gaining visibility into the industry’s manufacturing lifecycle. This visibility is necessary for aligning biopharmaceutical manufacturing processes more closely with demand. However, traditional methods for obtaining clear demand signals have proven insufficient due to data timeliness, completeness, and accuracy issues. As biopharma moves toward more personalized therapies, visibility into the manufacturing lifecycle and effective integration of manufacturing and supply chain operations is paramount.

The Value of Data Visibility

Data visibility can accelerate time-to-target identification and commercialization in biopharma manufacturing. It can also improve patient compliance and medication adherence, improving patient outcomes. However, data types' sheer volume, variety, and variability often complicate obtaining precise and accurate data. Robust data management strategies and advanced technologies are required to derive critical insights from the data effectively and efficiently.

Enhancing Patient Care with Data Visibility

Biopharma manufacturers can speed up the discovery of new drugs and create more personalized therapies that benefit patients' health by overcoming data visibility challenges. Better data visibility also helps patients follow their prescribed treatments and improves the effectiveness of medicines, leading to better overall healthcare. By embracing data visibility, life sciences manufacturers can boost their capabilities, make research breakthroughs, and provide significant value to the industry and patients they serve.